Does Cigna Cover Tadalafil (Generic)?

Cigna Formulary Placement for Generic Tadalafil

Generic tadalafil sits on Tier 1 or Tier 2 of most Cigna commercial formularies, which translates to the lowest copay brackets. Tier 1 preferred generics typically carry a $0 to $15 copay, while Tier 2 generics fall in the $15 to $45 range per 30-day fill.

The specific tier depends on your exact plan document. Cigna operates dozens of formulary variants across its PPO, HMO, and Open Access products. The standard Performance Prescription Drug List and the Standard Prescription Drug List are the two most common, and both include generic tadalafil. You can verify your plan's formulary by logging into myCigna.com and searching "tadalafil" under the drug-cost tool, or by calling the number on the back of your member ID card.

Tadalafil received FDA approval for ED in 2003 under the brand name Cialis, and for BPH in 2011. Generic versions became available in September 2018 after Eli Lilly's patent exclusivity expired. Since then, multiple manufacturers produce generic tadalafil in 2.5 mg, 5 mg, 10 mg, and 20 mg tablets. This broad generic competition is what dropped the average cash price from $450 per month (brand) to roughly $80 per month (generic), and insurance formulary placement has followed accordingly.

A randomized, double-blind trial by Brock et al. (N=1,112) demonstrated that tadalafil 20 mg improved erectile function scores by 7.9 points on the IIEF scale versus 1.2 points for placebo (P<0.001) [1]. That efficacy data, replicated across multiple phase III trials, underpins insurer willingness to cover the molecule.

Prior Authorization Requirements on Cigna

Cigna requires prior authorization for generic tadalafil when prescribed for ED on most commercial plans. The PA process is moderate in difficulty. Your prescriber submits a request confirming the diagnosis, the dose, and that the patient has no contraindications to PDE5 inhibitor therapy.

The standard clinical criteria Cigna applies for ED-indication PA include:

• A confirmed diagnosis of erectile dysfunction (ICD-10 N52.x)
• Age 18 or older
• No concurrent use of nitrate medications (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) due to the risk of severe hypotension
• No unstable cardiovascular disease within the past 90 days
• Documentation that the prescriber has assessed cardiovascular risk per the Princeton III Consensus Guidelines

For BPH-indication prescriptions (ICD-10 N40.x), some Cigna plans waive the PA requirement because daily low-dose tadalafil 5 mg is the only PDE5 inhibitor with an FDA-approved BPH indication. This can work in the patient's favor. If a man has both ED and BPH, a prescriber who codes the primary diagnosis as BPH may avoid the PA process entirely on certain Cigna formularies.

PA turnaround is typically 24 to 72 hours for standard requests. Urgent requests (defined by Cigna as situations where delay could seriously jeopardize life, health, or the ability to regain maximum function) receive a decision within 24 hours.

Step Therapy: Will Cigna Make You Try Sildenafil First?

Some Cigna plans enforce step therapy that requires a trial of sildenafil (generic Viagra) before approving tadalafil. The logic is cost-based: sildenafil generics often sit at a lower Tier 1 copay, sometimes $0 under certain preferred drug programs.

Step therapy does not apply to every Cigna plan. The requirement appears most often on the Standard Prescription Drug List and on employer-sponsored plans that have opted into step-edit protocols. The Performance Prescription Drug List is less likely to enforce step therapy for PDE5 inhibitors, though this varies by employer group.

If step therapy applies to your plan, the typical requirement is a 30-day trial of sildenafil at an adequate dose (25 mg, 50 mg, or 100 mg) with documented therapeutic failure or intolerable side effects. "Therapeutic failure" means the drug did not produce adequate erectile response on at least four separate attempts at the maximum tolerated dose.

There is a legitimate clinical reason a patient might need tadalafil instead of sildenafil: duration of action. Sildenafil's half-life is 3 to 5 hours, producing a 4-to-6-hour window of effectiveness. Tadalafil's half-life is 17.5 hours, producing up to a 36-hour window [2]. For men who prefer spontaneity or who take daily low-dose therapy for combined ED/BPH, tadalafil offers a pharmacokinetic profile that sildenafil cannot replicate. The Porst et al. preference study found that 73% of men who had tried both drugs preferred tadalafil, primarily citing the longer duration of action.

Your prescriber can request a step-therapy exception by documenting why tadalafil is medically necessary over sildenafil. Valid reasons include prior sildenafil failure, concurrent BPH requiring daily PDE5 inhibitor therapy, or a clinical need for extended-duration action due to the patient's dosing schedule or lifestyle requirements.

Quantity Limits and Dosing Covered by Cigna

Cigna applies quantity limits that align with FDA-approved dosing. The limits differ by strength and indication.

For daily dosing (ED or BPH), the standard quantity limit is 30 tablets per 30 days for tadalafil 2.5 mg or 5 mg. This matches the FDA-recommended once-daily regimen. A 2007 trial by Rajfer et al. (N=268) showed that tadalafil 5 mg daily improved IIEF-EF domain scores by 6.2 points versus 1.4 for placebo at 24 weeks, supporting the daily-dosing model.

For as-needed dosing (ED only), the typical limit is 6 to 12 tablets per 30 days for tadalafil 10 mg or 20 mg. Some plans cap at 6 tablets, others allow up to 12. The FDA label recommends taking 10 mg before anticipated sexual activity, with adjustment to 20 mg or down to 5 mg based on efficacy and tolerability. The recommended maximum frequency is once per 24 hours [3].

If you need more tablets than your plan's quantity limit allows, your prescriber can submit a quantity-limit exception with clinical documentation explaining why the higher quantity is medically necessary.

What Generic Tadalafil Costs with Cigna vs. Without Insurance

The price difference between insured and uninsured generic tadalafil is significant but not as dramatic as with some specialty medications.

With Cigna insurance and a Tier 1 formulary position, expect $0 to $15 per month for a 30-day supply of daily-dose tadalafil 5 mg. With Tier 2 placement, expect $15 to $45. These figures assume you have met any applicable deductible, which some Cigna plans require before prescription coverage activates.

Without insurance, generic tadalafil 5 mg (30 tablets) costs approximately $15 to $80 per month at retail pharmacies, depending on the pharmacy and whether you use a discount card. The wide range reflects competitive pricing among generics manufacturers. Costco and independent pharmacies tend to be at the lower end; chain retail pharmacies tend to be higher.

Brand Cialis remains available at a list price of roughly $450 per month. There is no clinical reason to use brand Cialis when generic tadalafil contains the identical active ingredient in the same dose, manufactured under the same FDA quality standards.

For patients on high-deductible Cigna plans who face full drug costs until meeting their deductible, manufacturer discount programs and pharmacy discount cards (GoodRx, RxSaver, Amazon Pharmacy) can reduce out-of-pocket costs to $8 to $25 per month for a 30-day supply of generic tadalafil.

How to Appeal a Cigna Denial for Tadalafil

If Cigna denies coverage for generic tadalafil, you have a structured appeal pathway. Cigna operates a two-level internal appeal process, followed by an external review through an independent review organization (IRO).

Level 1 Internal Appeal. You or your prescriber must file within 180 days of the denial. Submit a written appeal to the address on your denial letter, or call Cigna's appeal hotline. Include: the denial reference number, a letter from your prescriber explaining medical necessity, relevant clinical documentation (prior sildenafil failures, BPH diagnosis, cardiovascular assessment), and any supporting medical literature. Cigna must respond within 30 days for pre-service appeals and 60 days for post-service appeals.

Level 2 Internal Appeal. If Level 1 is upheld, you can request a second internal review. A different Cigna medical reviewer examines your case. Same documentation requirements and timeframes apply.

External IRO Review. If both internal levels deny coverage, you can request an external review by an independent third party. The IRO is not affiliated with Cigna and makes a binding coverage determination. This option is available under the Affordable Care Act's external review provisions for all non-grandfathered health plans.

Success rates on appeal improve substantially when the prescriber's letter addresses the specific denial reason. If the denial cites "not medically necessary," the appeal should include IIEF scores, documented treatment history, and references to clinical guidelines. If the denial cites "formulary alternative available," the appeal should explain why the alternative (usually sildenafil) is inadequate for this specific patient. The AUA/SMSNA 2018 guidelines on ED management support PDE5 inhibitor selection based on individual patient factors, including duration of action and dosing flexibility.

Tadalafil for BPH: A Coverage Advantage on Cigna

Tadalafil 5 mg daily is the only PDE5 inhibitor with FDA approval for treating the signs and symptoms of BPH, with or without concurrent ED [3]. This unique indication creates a coverage advantage on Cigna plans.

When prescribed specifically for BPH (ICD-10 N40.0 or N40.1), tadalafil may bypass ED-specific prior authorization requirements and quantity limits on certain Cigna formularies. The BPH indication also avoids step-therapy protocols that require sildenafil first, because sildenafil is not approved for BPH.

The clinical evidence for tadalafil in BPH is strong. A pooled analysis of four randomized trials (N=1,500) published in BJU International found that tadalafil 5 mg daily improved International Prostate Symptom Score (IPSS) by 4.6 to 5.6 points versus 2.3 to 3.6 for placebo at 12 weeks. Men with comorbid ED and BPH experienced simultaneous improvement in both conditions, making daily tadalafil a single-pill solution.

If your prescriber documents BPH symptoms (incomplete emptying, frequency, intermittency, urgency, weak stream, straining, or nocturia) alongside the BPH diagnosis code, the coverage path through Cigna becomes simpler. This is not about gaming the system. Roughly 50% of men with ED also have clinically significant BPH symptoms, per Rosen et al. (Eur Urol 2005), making dual-indication prescribing clinically appropriate in a large share of patients.

Using Manufacturer Savings Cards with Cigna

Eli Lilly, the original manufacturer of Cialis, has periodically offered savings cards for brand Cialis. These cards are generally not transferable to generic tadalafil. However, some generic tadalafil manufacturers and specialty pharmacies offer their own discount programs.

The key rule: manufacturer savings cards typically cannot be used with government-funded insurance (Medicare, Medicaid, Tricare, VA). For Cigna commercial plans, savings cards can usually be applied as secondary coverage to offset your copay, unless your specific plan prohibits copay accumulator or copay maximizer programs.

Cigna has implemented copay accumulator programs on some employer plans. Under a copay accumulator, manufacturer savings card payments do not count toward your annual deductible or out-of-pocket maximum. This means you might use a savings card for the first few months of the year, then face full cost when the card's value runs out, without having made progress toward your deductible. Check your plan's Summary of Benefits and Coverage document for language about "copay accumulator adjustment" or "out-of-pocket protection program" to determine whether this applies.

For most Cigna commercial members filling generic tadalafil, the copay is low enough ($0 to $45) that a manufacturer savings card provides minimal additional benefit. The savings card strategy is more relevant for patients whose plans still require brand Cialis or whose deductible has not been met.

Compounded Tadalafil and Cigna: A Different Story

Compounded tadalafil (custom-prepared by a compounding pharmacy, often in non-standard doses like 6 mg, 9 mg, or in combination with other drugs) follows a different coverage pathway on Cigna. Most Cigna plans do not cover compounded medications on the standard pharmacy benefit. Some plans offer a separate compounding benefit with precertification requirements.

If your prescriber orders compounded tadalafil, expect Cigna to require precertification demonstrating that no commercially available dosage form meets your clinical needs. Approval rates for compounded PDE5 inhibitors are low unless there is a documented allergy to an inactive ingredient in the manufactured tablet or a need for a dose that cannot be achieved by splitting or combining commercially available strengths.

The cost of compounded tadalafil without insurance varies widely ($30 to $200 per month) depending on the compounding pharmacy, the formula, and the dose. Given that generic tadalafil is available in four manufactured strengths (2.5 mg, 5 mg, 10 mg, 20 mg) at $15 to $80 per month cash-pay, the clinical justification for compounding is narrow.